ArticleEClinicalMedicine2024

Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial.

Dhammika Leshan Wannigama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.